Publication:
A randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer

Simple item page
dc.contributor.authorDANE, FAYSAL
dc.contributor.authorsYalcin, S.; Uslu, R.; Dane, F.; Yilmaz, U.; Zengin, N.; Buyukunal, E.; Buyukberber, S.; Camci, C.; Sencan, O.; Kilickap, S.
dc.date.accessioned2022-03-10T17:50:51Z
dc.date.accessioned2026-01-11T17:34:07Z
dc.date.available2022-03-10T17:50:51Z
dc.date.issued2011
dc.identifier.doi10.1200/jco.2011.29.4_suppl.474
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/221405
dc.identifier.wosWOS:000208847100471
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleA randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.issue4
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume29

Files

Collections

Araştırma Çıktıları